Clarius Group LLC’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.2K | Hold |
10,000
| – | – | 0.01% | 469 |
|
|
2025
Q1 | $79.5K | Hold |
10,000
| – | – | 0.01% | 473 |
|
|
2024
Q4 | $54.3K | Hold |
10,000
| – | – | ﹤0.01% | 447 |
|
|
2024
Q3 | $72.2K | Hold |
10,000
| – | – | 0.01% | 447 |
|
|
2024
Q2 | $109K | Hold |
10,000
| – | – | 0.01% | 435 |
|
|
2024
Q1 | $187K | Hold |
10,000
| – | – | 0.01% | 462 |
|
|
2023
Q4 | $217K | Sell |
10,000
-994
| -9% | -$21.5K | 0.02% | 435 |
|
|
2023
Q3 | $226K | Buy |
10,994
+240
| +2% | +$4.94K | 0.02% | 408 |
|
|
2023
Q2 | $506K | Hold |
10,754
| – | – | 0.04% | 258 |
|
|
2023
Q1 | $451K | Hold |
10,754
| – | – | 0.04% | 282 |
|
|
2022
Q4 | $410K | Buy |
10,754
+28
| +0.3% | +$1.07K | 0.04% | 292 |
|
|
2022
Q3 | $420K | Buy |
10,726
+549
| +5% | +$21.5K | 0.04% | 255 |
|
|
2022
Q2 | $329K | Buy |
+10,177
| New | +$329K | 0.03% | 316 |
|
|
2020
Q4 | – | Sell |
-35,500
| Closed | -$2.17M | – | 357 |
|
|
2020
Q3 | $2.17M | Hold |
35,500
| – | – | 0.28% | 42 |
|
|
2020
Q2 | $1.48M | Hold |
35,500
| – | – | 0.21% | 57 |
|
|
2020
Q1 | $1.02M | Hold |
35,500
| – | – | 0.19% | 63 |
|
|
2019
Q4 | $2.66M | Buy |
+35,500
| New | +$2.66M | 0.42% | 31 |
|
|
2017
Q4 | – | Sell |
-129,068
| Closed | -$8.04M | – | 72 |
|
|
2017
Q3 | $8.04M | Sell |
129,068
-20,000
| -13% | -$1.25M | 3.39% | 4 |
|
|
2017
Q2 | $11.9M | Hold |
149,068
| – | – | 4.89% | 4 |
|
|
2017
Q1 | $10.6M | Hold |
149,068
| – | – | 4.37% | 4 |
|
|
2016
Q4 | $7.91M | Hold |
149,068
| – | – | 3.35% | 5 |
|
|
2016
Q3 | $6.87M | Hold |
149,068
| – | – | 3.2% | 4 |
|
|
2016
Q2 | $4.49M | Buy |
149,068
+38,118
| +34% | +$1.15M | 2.39% | 7 |
|
|
2016
Q1 | $3.56M | Buy |
+110,950
| New | +$3.56M | 1.97% | 8 |
|